Recombinant polyclonal antibodies: Therapeutic antibody technologies come full circle

IDrugs

Volumn 8, Issue 5, 2005, Pages 404-409

  Haurum, John ^a   Bregenholt, Søren ^a  

^a Symphogen AS   (Denmark)

Author keywords

Antibody technology; Monoclonal antibodies; Recombinant polyclonal antibodies; Sympress

Indexed keywords

ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; DIGOXIN ANTIBODY; EPITOPE; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; POLYCLONAL ANTIBODY; RABIES IMMUNOGLOBULIN; RHESUS D ANTIBODY; SNAKE VENOM; TETANUS ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; DISEASE ASSOCIATION; GENE MUTATION; GENETIC VARIABILITY; GRAFT REJECTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFECTION RATE; INFECTION RISK; MICROORGANISM; PROPHYLAXIS; SEPSIS; STAPHYLOCOCCUS INFECTION; VACCINATION; WHOLE CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; DRUG INDUSTRY; EPITOPES; HUMANS; RECOMBINANT PROTEINS; TECHNOLOGY, PHARMACEUTICAL;

EID: 18144368138     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Brekke OH, Sandlie I: Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Disc (2003) 2 (1):52-62.
2. Casadevall A, Dadachova E, Pirofski LA: Passive antibody therapy for infectious diseases. Nat Rev Microbiol (2004) 2(9):695-703.
3. Ferrantelli F, Ruprecht RM: Neutralizing antibodies against HIV - back in the major leagues? Curr Opin Immunol (2002) 14(4):495-502.
4. Bregenholt S, Haurum J: Pathogen-specific recombinant human polyclonal antibodies: Biodefence applications. Expert Opin Biol Ther (2004) 4(3):387-396.